Amgen Boosts US Manufacturing with $300M Investment, Nearing $2B Total in a Year
AMGN sits 26% above its 52-week low of $261.43.
Summary
Amgen announced an additional $300 million investment in its U.S. manufacturing operations, bringing its total capital expenditure in this area to nearly $2 billion over the last year. This investment includes expanding its Puerto Rico facility and is expected to create hundreds of construction jobs. This significant capital allocation demonstrates Amgen's commitment to strengthening its production capacity and supply chain, signaling confidence in future demand for its products and supporting long-term growth. This news follows recent positive Q1 earnings reports and represents a strategic move to enhance operational capabilities.
At the time of this announcement, AMGN was trading at $328.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $178B. The 52-week trading range was $261.43 to $391.29. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.